scholarly journals False-Negative Results in Detection of Monoclonal Proteins by Capillary Zone Electrophoresis: A Prospective Study

2001 ◽  
Vol 47 (8) ◽  
pp. 1477-1479 ◽  
Author(s):  
Xavier Bossuyt ◽  
Godelieve Mariën
1998 ◽  
Vol 110 (4) ◽  
pp. 503-509 ◽  
Author(s):  
Jerry A. Katzmann ◽  
Raynell Clark ◽  
Elizabeth Sanders ◽  
James P. Landers ◽  
Robert A. Kyle

Author(s):  
Fabian Derigs ◽  
Samuel Doryumu ◽  
Fabian Tollens ◽  
Dominik Nörenberg ◽  
Manuel Neuberger ◽  
...  

Abstract Purpose Magnetic resonance imaging (MRI)/ultrasound-fusion prostate biopsy (FB) comprises multiple steps each of which can cause alterations in targeted biopsy (TB) accuracy leading to false-negative results. The aim was to assess the inter-operator variability of software-based fusion TB by targeting the same MRI-lesions by different urologists. Methods In this prospective study, 142 patients eligible for analysis underwent software-based FB. TB of all lesions (n = 172) were carried out by two different urologists per patient (n = 31 urologists). We analyzed the number of mismatches [overall prostate cancer (PCa), clinically significant PCa (csPCa) and non-significant PCa (nsPCa)] between both performed TB per patient. In addition we evaluated factors contributing to inter-operator variability by uni- and multivariable analyses. Results In 11.6% of all MRI-lesions (10.6% of all patients) there was a mismatch between TB1 and TB2 in terms of overall prostate cancer (PCa detection. Regarding csPCa, patient-based mismatch occurred in 14.8% (n = 21). Overall PCa and csPCa detection rate of TB1 and TB2 did not differ significantly on a per-patient and per-lesion level. Analyses revealed a smaller lesion size as predictive for mismatches (OR 9.19, 95% CI 2.02–41.83, p < 0.001). Conclusion Reproducibility and precision of targeting particularly small lesions is still limited although using software-based FB. Further improvements in image-fusion, segmentation, needle-guidance, and automatization are necessary.


1979 ◽  
Vol 9 (2) ◽  
pp. 170-174
Author(s):  
N Pyndiah ◽  
U Krech ◽  
P Price ◽  
J Wilhelm

The indirect immunofluorescent (IIF) antibody technique for the detection of Toxoplasma gondii immunoglobulin M (IgM) often gives false negative results, probably due to the competition between IgG and IgM. We therefore adapted a gel filtration procedure for the separation of IgG and IgM to a routine diagnostic test capable handling at least 10 sera per day and requiring only 50 microliters of serum. The results from 108 sera having positive complement fixation titers for Toxoplasma showed that 17 were IgM positive when the whole serum was tested by IIF compared with 55 positive when the IgM fraction was used. Sera with antideoxyribonucleic acid titers do not give false positive results after fractionation, and the removal of IgG eliminates false positive results due to rheumatoid factor. A prospective study showed that Toxoplasma IgM may persist up to 9 months.


2002 ◽  
Vol 48 (9) ◽  
pp. 1600-1601 ◽  
Author(s):  
Godelieve Mariën ◽  
Els Oris ◽  
Arthur R Bradwell ◽  
Norbert Blanckaert ◽  
Xavier Bossuyt

2001 ◽  
Vol 91 (10) ◽  
pp. 508-514 ◽  
Author(s):  
Mitchell A. Barber ◽  
Janice Conolley ◽  
Cecily M. Spaulding ◽  
A. Lee Dellon

A prospective study of 29 patients with diabetic neuropathy and 47 nondiabetic patients with tarsal tunnel syndrome were evaluated with computer-assisted neurosensory testing at three sites on the foot. The sensitivity and specificity of one-point static touch thresholds for identifying the presence of large fiber axonal loss was done using the calculated thresholds for monofilaments derived from their markings. The sensitivity for one-point static touch in identifying axonal loss was 33% for the 5.07, 38% for the 4.93, 50% for the 4.17, and 60% for the 4.08 monofilament-equivalent, with a specificity of 100% at each level. Therefore, one-point static touch testing, even using monofilaments thinner than 5.07, has a high percentage of false-negative results in identifying patients with axonal loss. (J Am Podiatr Med Assoc 91(10): 508-514, 2001)


Author(s):  
D Stoian ◽  
M Craciunescu ◽  
M Craina ◽  
S Pantea ◽  
F Varcus

Sign in / Sign up

Export Citation Format

Share Document